Kondo M, Suzuki T, Kawano Y, Kojima S, Miyashiro M, Matsumoto A, Kania G, Blyszczuk P, Ross R, Mulipa P, Del Galdo F, Zhang Y, Distler J (2022)
Publication Type: Journal article
Publication year: 2022
Publisher: BMJ PUBLISHING GROUP
City/Town: LONDON
Pages Range: 488-488
Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES
DOI: 10.1136/annrheumdis-2022-eular.29
APA:
Kondo, M., Suzuki, T., Kawano, Y., Kojima, S., Miyashiro, M., Matsumoto, A.,... Distler, J. (2022). DERSIMELAGON, A NOVEL ORAL MELANOCORTIN 1 RECEPTOR AGONIST, DEMONSTRATES DISEASE-MODIFYING EFFECTS IN PRECLINICAL MODELS OF SYSTEMIC SCLEROSIS. Annals of the Rheumatic Diseases, 488-488. https://doi.org/10.1136/annrheumdis-2022-eular.29
MLA:
Kondo, M., et al. "DERSIMELAGON, A NOVEL ORAL MELANOCORTIN 1 RECEPTOR AGONIST, DEMONSTRATES DISEASE-MODIFYING EFFECTS IN PRECLINICAL MODELS OF SYSTEMIC SCLEROSIS." Annals of the Rheumatic Diseases (2022): 488-488.
BibTeX: Download